TITLE: Third in Series on Medicare Reform: Laying the Groundwork for a Rx Drug Benefit

CIS-NO: 2001-H781-96  
SOURCE: Committee on Ways and Means. House  
DOC-TYPE: Hearing Retrieve the full text of testimony  
DATE: Mar. 27, 2001  
LENGTH: iii+84 p.  
CONG-SESS: 107-1  
ITEM-NO: 1028-A; 1028-B  
SUDOC: Y4.W36:107-7  
 
GPO-STOCK-NO: 552-070-27441-3.

SUMMARY:
Committee Serial No. 107-7. Hearing before the Subcom on Health to examine proposals to establish an outpatient prescription drug benefit for medicare beneficiaries (Subcom advisory, p. 2-3).
 
Supplementary material (p. 83-84) includes a submitted statement.

CONTENT-NOTATION: Medicare prescription drug benefit proposals

DESCRIPTORS:  
   SUBCOM ON HEALTH, WAYS AND MEANS. HOUSE;  MEDICARE; DRUGS; MEDICAL REGULATION; MANAGED HEALTH CARE

01-H781-96 TESTIMONY NO: 1     Mar. 27, 2001 p. 9-43
 
WITNESSES (and witness notations):
   CRIPPEN, DAN L. (Director, CBO)
 
STATEMENT AND DISCUSSION:
   Analysis of costs associated with inclusion of prescription drug coverage in medicare benefits (related tables and graphs, p. 19-26); financial issues related to proposed medicare prescription drug benefit.
 
CONTENT NOTATION:
   Medicare prescription drug benefit proposals
 
TESTIMONY DESCRIPTORS:
   CONGRESSIONAL BUDGET OFFICE; STATISTICAL DATA: HEALTH AND VITAL STATISTICS; STATISTICAL DATA: PUBLIC WELFARE AND SOCIAL SECURITY
 
 
01-H781-96 TESTIMONY NO: 2     Mar. 27, 2001 p. 43-83
 
WITNESSES (and witness notations):
   POISAL, JOHN A. (Statistician, Office of Strategic Planning, Health Care Financing Administration)
   COHEN, MICHAEL R. (President, Institute for Safe Medication Practices)
   FREDERICK, HELEN
   WILKINSON, LORE (both medicare beneficiaries)
   RICHTMAN, MAX (Executive Vice President, National Committee To Preserve Social Security and Medicare)
   MACGUINEAS, MAYA (National Board Member, Third Millennium)
 
STATEMENTS AND DISCUSSION:
   Importance of establishing medicare prescription drug benefits, with related policy recommendations; strategies to reduce incidence of medication errors; issues related to establishment of medicare prescription drug benefits.
 
CONTENT NOTATION:
   Medicare prescription drug benefit proposals
 
TESTIMONY DESCRIPTORS:
   INSTITUTE FOR SAFE MEDICATION PRACTICES; NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE; THIRD MILLENNIUM; HEALTH CARE FINANCING ADMINISTRATION

LOAD-DATE: November 22, 2002